Effects of Testosterone Administration in Human Immunodeficiency Virus-Infected Women with Low Weight: A Randomized Placebo-Controlled Study

Archives of Internal Medicine

Volumn 164, Issue 8, 2004, Pages 897-904

  Dolan, Sara ^a   Wilkie, Stephanie ^a   Aliabadi, Negar ^a   Sullivan, Meghan P ^a   Basgoz, Nesli ^a   Davis, Benjamin ^a   Grinspoon, Steven ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; PLACEBO; TESTOSTERONE;

ACNE; ADULT; ALOPECIA; ANALYSIS OF VARIANCE; ARM; ARTICLE; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CALCULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG TOLERABILITY; FEMALE; GLUCOSE BLOOD LEVEL; HIRSUTISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE FUNCTION TEST; KNEE FUNCTION; LARYNX DISORDER; LEG; LIBIDO DISORDER; LIPID BLOOD LEVEL; LIVER FUNCTION; MAJOR CLINICAL STUDY; MUSCLE STRENGTH; PREDICTION; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SHOULDER; SIDE EFFECT; URINARY EXCRETION; WEIGHT REDUCTION;

ADULT; ANDROGENS; BODY COMPOSITION; BODY WEIGHT; CD4 LYMPHOCYTE COUNT; ENERGY INTAKE; FEMALE; HIV INFECTIONS; HUMANS; MUSCLE, SKELETAL; NUTRITION ASSESSMENT; TESTOSTERONE; VIRAL LOAD;

EID: 1942501219     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.164.8.897     Document Type: Article

References (36)

1. Hader SL, Smith DK, Moore JS, Holmberg SD. HIV infection in women in the United States: status at the Millennium. JAMA. 2001;285:1186-1192.
2. Massachusetts Department of Public Health. HIV/AIDS in Massachusetts: An Epidemiologic Profile, Fiscal Year 2001. Boston: Massachusetts Dept of Public Health, HIV/AIDS Bureau; 2001:27-81.
3. Shapiro MF, Morton SC, McCaffrey DF, et al. Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. JAMA. 1999;281:2305-2315.
4. Palacio H, Shiboski CH, Yelin EH, Hessol NA, Greenblatt RM. Access to and utilization of primary care services among HIV-infected women. J Acquir Immune Defic Syndr. 1999;21:293-300.
5. Grinspoon S, Corcoran C, Miller K, et al. Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting. J Clin Endocrinol Metab. 1997;82:1332-1337.
6. Sinha-Hikim I, Arver S, Beall G, et al. The use of a sensitive equilibrium dialysis method in the measurement of free testosterone levels in healthy cycling women and human immunodeficiency virus-infected women. J Clin Endocrinol Metab. 1998;83:1312-1318.
7. Miller K, Corcoran C, Armstrong C, et al. Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study. J Clin Endocrinol Metab. 1998;83:2717-2725.
8. Lorenzo E. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 1970;31:556.
9. Kratz A, Lewandrowaki KB. Case records of the Massachusetts General Hospital: weekly clinicopathological exercises: normal reference laboratory values. N Engl J Med. 1998;339:1063-1072.
10. 1983 metropolitan height and weight tables. Stat Bull Metrop Life Found. 1983;64:3-9.
11. Mazess RB, Barden HS, Bisek JP, Hanson J. Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr. 1990;51:1106-1112.
12. Grinspoon S, Corcoran C, Askari H, et al. Effects of androgen administration in men with AIDS wasting: a randomized, placebo-controlled, trial. Ann Intern Med. 1998;129:18-26.
13. Borkan GA, Gerzof SG, Robbins AH, Hults DE, Silbert CK, Silbert JE. Assessment of abdominal fat content by computed tomography. Am J Clin Nutr. 1982;36:172-177.
14. Kohl HW, Blair SN, Paffenberger RS, Macera CA, Kronenfeld JJ. A mail survey of physical activity habits as related to measured physical fitness. Am J Epidemiol. 1988;127:1228-1239.
15. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-571.
16. Munsat TL, Andres PL, Skerry LM. Quantitative assessment of deficit in amyotrophic lateral sclerosis. Phys Med Rehabil State Art Rev. 1989;3:188-193.
17. Andres PL, Hedlund W, Finison L, Conlon T, Felmus M, Munsat TL. Quantitative motor assessment in amyotrophic lateral sclerosis. Neurology. 1986;36:937-941.
18. The National Isometric Muscle Strength (NIMS) Database Consortium. Muscular weakness assessment: use of normal isometric strength data. Arch Phys Med Rehabil. 1996;77:1251-1255.
19. Grinspoon S, Corcoran C, Rosenthal D, et al. Quantitative assessment of cross-sectional muscle area, functional status and muscle strength in men with the AIDS wasting syndrome. J Clin Endocrinol Metab. 1999;84:201-206.
20. Guyatt GH, Thompson PJ, Berman LB, et al. How should we measure function in patients with chronic heart and lung disease. J Chron Dis. 1985;38:517-524.
21. Dixon WJ, Massey FJ. Introduction to Statistical Analysis. 2nd ed. New York, NY: McGraw-Hill Co; 1957.
22. Wanke C, Silva M, Knox T, Forrester J, Speigelman D, Gorbach S. Weight loss and wasting remain common complications in individuals infected with HIV in the era of highly active antiretroviral therapy. Clin Infect Dis. 2000;31:803-805.
23. Wilson IB, Cleary PD. Clinical predictors of functioning in persons with acquired immunodeficiency syndrome. Med Care. 1996;34:610-623.
24. Crystal S, Fleishman JA, Hays RD, Shapiro MF, Bozzette SA. Physical and role functioning among persons with HIV: results from a nationally representative survey. Med Care. 2000;38:1210-1223.
25. Shifren JL, Braunstein GD, Simon JA, et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med. 2000;343:682-688.
26. Fleishman JA, Crystal S. Functional status transitions and survival in HIV disease: evidence from the AIDS Costs and Service Utilization Survey. Med Care. 1998;36:533-543.
27. Clemmons DR, Klibanski A, Underwood LE, et al. Reduction of plasma immunoreactive somatomedin C during fasting in humans. J Clin Endocrinol Metab. 1981;53:1247-1250.
28. Liu L, Merriam GR, Sherins RJ. Chronic sex steroid exposure increases mean plasma growth hormone concentration and pulse amplitude in men with isolated hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 1987;64:651-656.
29. Ulloa-Aguirre A, Blizzard RM, Garcia-Rubi E, et al. Testosterone and oxandrolone, a nonaromatizable androgen, specifically amplify the mass and rate of growth hormone (GH) secreted per burst without altering GH secretory burst duration or frequency or the GH half-life. J Clin Endocrinol Metab. 1990;71:846-854.
30. Hobbs CJ, Plymate SR, Rosen CJ, Adler RA. testosterone administration increases insulin-like growth factor-I levels in normal men. J Clin Endocrinol Metab. 1993;77:776-779.
31. Gordon CM, Grace E, Emans SJ, et al. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial. J Clin Endocrinol Metab. 2002;87:4935-41.
32. Rosenfeld RG, Hintz RL, Johanson AJ, et al. Three-year results of a randomized prospective trial of methionyl human growth hormone and oxandrolone in Turner's Syndrome. J Pediatr. 1988;113:393-400.
33. Waters D, Danska J, Hardy K, et al. Recombinant human growth hormone, insulin-like growth factor 1, and combination therapy in AIDS-associated wasting: a randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1996;125:865-872.
34. Fisher A, Abbaticola M. The Effects of oxandrolone on body weight and composition in patients with HIV-associated weight loss. Presented at: The 12th World AIDS Conference; June 28-July 3, 1998; Geneva, Switzerland.
35. Oster MH, Enders SR, Samuels SJ, et al. Megestrol acetate in patients with AIDS and cachexia. Ann Intern Med. 1994;121:400-408.
36. Schambelan M, Mulligan K, Grunfeld C, et al, Serostim Study Group. Recombinant human growth hormone in patients with HIV-associated wasting: a randomized, placebo-controlled trial. Ann Intern Med. 1996;125:873-882.